American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 50-60, January 2010

Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group

  • Melanie S. Joy, PharmD

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Debbie S. Gipson, MD, MSPH

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Leslie Powell, RN, CPNP

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Jacqueline MacHardy, BS

      Affiliations

    • UNC Kidney Center and Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • J. Charles Jennette, MD

      Affiliations

    • Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Suzanne Vento, RN

      Affiliations

    • Division of Nephrology, Schneider Children's Hospital of North Shore-LIJ Health System, New Hyde Park, NY
    • ,
  • Cynthia Pan, MD

      Affiliations

    • Departments of Pediatrics and Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Virginia Savin, MD

      Affiliations

    • Departments of Pediatrics and Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI
    • ,
  • Allison Eddy, MD

      Affiliations

    • Division of Nephrology, Seattle Children's Hospital, Seattle, WA
    • ,
  • Agnes B. Fogo, MD

      Affiliations

    • Department of Pathology, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Jeffrey B. Kopp, MD

      Affiliations

    • Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Kidney Diseases Branch, National Institutes of Health, Bethesda, MD
    • ,
  • Daniel Cattran, MD, FRCPC

      Affiliations

    • Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
    • ,
  • Howard Trachtman, MD

      Affiliations

    • Division of Nephrology, Schneider Children's Hospital of North Shore-LIJ Health System, New Hyde Park, NY
    • Corresponding Author InformationAddress correspondence to Howard Trachtman, MD, Schneider Children's Hospital, Division of Nephrology, 269-01 76th Ave, New Hyde Park, NY 11040

Received 21 April 2009; accepted 17 August 2009. published online 23 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2009.08.019 on November 23, 2009.

 Trial registration: www.ClinicalTrials.gov; study number: NCT00814255.

PII: S0272-6386(09)01188-3

doi:10.1053/j.ajkd.2009.08.019

American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 50-60, January 2010

Article Tools

* Image Usage & Resolution